XML 25 R16.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Stock-Based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract] |
Stock-Based Compensation | Stock-Based Compensation There have been no material changes to the terms of our 2018 Equity Incentive Plan (the "2018 Plan"), 2018 Employee Stock Purchase Plan ("2018 ESPP") and 2009 Equity Incentive Plan ("2009 Plan") since the filing of our Annual Report on Form 10-K. Refer to Note 14, Stock-Based Compensation, in our Annual Report on Form 10-K filed with the SEC on April 7, 2022 for more information on our various equity incentive plans. 2018 Equity Incentive Plan Shares of common stock reserved for issuance under the 2018 Plan also will include any shares of common stock subject to stock options, restricted stock units or similar awards granted under the 2009 Plan, that, on or after the adoption of the 2018 Plan, expire or otherwise terminate without having been exercised in full and shares of common stock issued pursuant to awards granted under the 2009 Plan that are forfeited to or repurchased by us. As of September 30, 2022, the maximum number of shares of common stock that may be added to the 2018 Plan pursuant to the foregoing is 897,229. Not including the maximum number of shares from the 2009 Plan that may be added to the 2018 Plan, the 2018 Plan had 2,272,435 and 762,038 shares of common stock reserved for future issuances as of September 30, 2022 and December 31, 2021, respectively. Restricted Stock Units A summary of our restricted stock unit activity under the 2018 Plan for the nine months ended September 30, 2022 is set forth below:
| Shares |  | Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2021 | 3,576,270 |  |  | $ | 1.94 |
Granted | 1,292,000 |  |  | 1.58 |
Released | (1,409,494) |  |  | 1.76 |
Forfeited | (105,000) |  |  | 2.22 |
Outstanding as of September 30, 2022 | 3,353,776 |  |  | $ | 1.86 |
During the third quarter of 2022, we granted 1,267,000 restricted stock unit awards to team members with an average grant date fair value of $1.57 per share. The awards granted to team members vest over a range of 39 to 49 months with various installment and vesting dates, and are subject to service conditions. We also granted 25,000 restricted stock units to non-employee, each with a grant date fair value of $1.70. The award vest on March 31, 2023 and are subject to service conditions. Stock Options A summary of our stock option activity under the 2018 Plan and related information is as follows:
| Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (years) |  | Aggregate Intrinsic Value
Outstanding as of December 31, 2021 | 50,000 |  |  | $ | 1.08 |  |  | 1.37 |  | $ | 78 |
Granted | 50,000 |  |  | 1.70 |  |  |  |  |
Exercised | — |  |  | — |  |  |  |  |
Forfeited | (12,500) |  |  | 1.08 |  |  |  |  |
Outstanding as of September 30, 2022 | 87,500 |  |  | $ | 1.43 |  |  | 5.9 |  | $ | 4 |
Exercisable as of September 30, 2022 | 68,750 |  |  | $ | 1.36 |  |  | 4.82 |  | $ | 4 |
During third quarter of 2022, we granted options to purchase 50,000 shares of our common stock to two non-employee consultants with an exercise price of $1.70 per share. The options vest over five months with half on August 30, 2022, then four equal monthly installments until December 30, 2022. 2018 Employee Stock Purchase Plan We use a Black-Scholes option pricing model to determine the fair value of shares to be purchased under the 2018 ESPP. Stock-based compensation expense related to our 2018 ESPP for the three and nine months ended September 30, 2022 was not significant. There were 911,245 and 189,215 shares of common stock available for sale and reserved for issuance as of September 30, 2022 and December 31, 2021, respectively. 2009 Equity Incentive Plan A summary of our stock option activity under the 2009 Plan and related information is as follows:
| Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (years) |  | Aggregate Intrinsic Value
Outstanding as of December 31, 2021 | 925,467 |  |  | $ | 0.80 |  |  | 5.59 |  | $ | 1,692 |
Granted | — |  |  | — |  |  |  |  |
Exercised | (22,757) |  |  | 0.68 |  |  |  |  |
Forfeited | (5,481) |  |  | 2.00 |  |  |  |  |
Outstanding as of September 30, 2022 | 897,229 |  |  | $ | 0.80 |  |  | 4.96 |  | $ | 452 |
Exercisable as of September 30, 2022 | 896,155 |  |  | $ | 0.80 |  |  | 4.96 |  | $ | 452 |
For the nine months ended September 30, 2022, the aggregate intrinsic value of options exercised was $42 and the total fair value of options vested was $16. Stock-Based Compensation Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive (loss) income for all stock-based compensation arrangements is set forth below:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
Stock-based compensation | 2022 |  | 2021 |  | 2022 |  | 2021
Cost of revenues | $ | 59 |  |  | $ | 352 |  |  | $ | 154 |  |  | $ | 884 |
Sales and marketing | 35 |  |  | 140 |  |  | 80 |  |  | 371 |
General and administrative | 760 |  |  | 790 |  |  | 1,827 |  |  | 2,124 |
Research and development | 45 |  |  | 213 |  |  | 108 |  |  | 554 |
Total stock-based compensation | $ | 899 |  |  | $ | 1,495 |  |  | $ | 2,169 |  |  | $ | 3,933 |
As of September 30, 2022, there was approximately $5,702, $224 and $1 of total unrecognized compensation cost related to the 2018 Plan, the 2018 ESPP and the 2009 Plan, respectively. These unrecognized compensation costs are expected to be recognized over an estimated weighted-average period of approximately 2.7 years, 1.1 years and 0.8 years for the 2018 Plan, the 2018 ESPP and 2009 Plan, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (l) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration